Drugs designed to clear amyloid beta from the brain—once seen as a promising path to slowing Alzheimer’s—may not actually ...
Alzheimer's Disease," Cleveland Clinic behavioral neurologist Jagan Pillai, MD, PhD, and host Glenn Campbell continue their ...
Morning Overview on MSN
The Alzheimer’s protein Sox9 works by waking up astrocytes and activating a receptor called MEGF10 that eats amyloid plaques
For decades, Alzheimer’s research has centered on neurons, the brain cells that die as the disease progresses, and on the ...
A major review challenges a long-standing strategy in Alzheimer’s research, suggesting that removing a hallmark brain protein ...
Morning Overview on MSN
Scientists discover a single protein that forces the brain to clean out its own Alzheimer’s plaques
A Colombian man carried one of the most aggressive genetic mutations known to cause early-onset Alzheimer’s disease. By all ...
Scientists have discovered a way to help the brain clean itself of harmful Alzheimer’s plaques by activating its own support cells. By increasing a protein called Sox9, researchers were able to boost ...
A newly published Cochrane systematic review examining amyloid-beta-targeting monoclonal antibodies in Alzheimer's disease ...
At WIRED Health, pioneering Alzheimer's researcher John Hardy outlined the stakes—and next steps—of where treatment is headed ...
Findings showed 91.7% of patients with positive results using Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio test had amyloid plaques based on PET scan or CSF test results. The Food and Drug ...
Scientists have discovered a way to activate a built-in brain cleanup system that may help counter Alzheimer’s disease. By ...
Alzheimer’s Research UK says patients at risk of being left behind as lack of formal or accurate diagnoses closes door to trials ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results